2024-09-03 - Analysis Report
## TMO Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc. (TMO) is a leading provider of scientific instruments, consumables, software, and services for research, analysis, discovery, and diagnostics.

**Performance Analysis:**

**1. Relative Performance:**
* **Cumulative Return:** TMO has generated a cumulative return of **114.73%**, outperforming the S&P 500 (VOO) with a return of **89.66%**. This translates to a **25.07%** outperformance compared to the benchmark index.
* **Relative Outperformance:** The current relative outperformance of TMO compared to VOO is within the 29.58% percentile range historically, suggesting a solid but not exceptional performance relative to the broader market.

**2. Recent Price Action:**
* **Closing Price:** $615.07
* **5-Day Moving Average:** $611.18
* **20-Day Moving Average:** $604.74
* **60-Day Moving Average:** $578.32

The stock is currently trading above all three moving averages, indicating a short-term uptrend. The relatively close proximity of the 5-day and 20-day moving averages suggests a potential consolidation phase.

**3. Technical Indicators:**
* **RSI:** 67.56, indicating the stock is in overbought territory, potentially signaling a near-term correction.
* **PPO:** -0.13, indicating a slightly bearish momentum, although not strong enough to signal a major downtrend.
* **Delta_Previous_Relative_Divergence:** -11.79, indicating a recent short-term downward trend in relative performance.
* **Expected Return:** 61.82%, representing the projected maximum potential return over 5 years based on current investment levels.

**4. Recent Earnings and Outlook:**

| Date       | EPS    | Revenue        |
|------------|--------|-----------------|
| 2024-08-02 | 4.05   | 10.54 B$        |
| 2024-05-03 | 3.47   | 10.35 B$        |
| 2023-11-03 | 4.44   | 10.57 B$        |
| 2023-08-04 | 3.53   | 10.69 B$        |
| 2024-08-02 | 3.53   | 10.69 B$        |

The most recent earnings release (2024-08-02) showed an EPS of 4.05, exceeding analyst expectations. Revenue was also above expectations, confirming strong growth for the company. TMO's consistent revenue growth and strong earnings demonstrate its resilient business model and robust demand for its products and services.

**5. Conclusion:**

TMO exhibits strong financial performance with consistent revenue growth and exceeding earnings expectations. Although the stock is currently in overbought territory based on RSI, the strong earnings performance suggests the potential for continued growth. However, it is important to note that the recent short-term decline in relative outperformance and negative PPO signal a potential near-term correction. Overall, TMO remains a promising investment opportunity with strong fundamentals and a track record of outperforming the market. Investors should monitor technical indicators closely for potential short-term volatility and adjust their investment strategy accordingly. 
